Therapy has been developed to reduce the frequency, duration and severity of migraine attacks
News
King’s College London and Pioneer Group in incubator link-up
Collaboration aims to revitalise two empty sites on the South Bank of London by providing several laboratories
DigitalHealth.London’s Accelerator programme selects Aide
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions
BMS’ Sotyktu gets NICE green light for NHS use
The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults
Edinburgh researchers and LifeArc to boost MND treatment processes
Partnership will establish drug candidates using both laboratory tests and machine-learning
Genfit and Ipsen announce elafibranor results
ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint
University of Oxford and PrecisionLife reach data agreement
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis
Momentum for Poolbeg and CytoReason’s AI collaboration
Partnership establishes several influenza therapy targets using artificial intelligence
TME Pharma reveals positive NOX-A12 data
GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients
Positive results for Astellas’ Fezolinetant
Trial involved over 450 women across Europe, Turkey and Canada who were unsuitable for hormone therapy
Positive results for Evgen’s rhabdomyosarcoma therapy
Update on radiosensitising impact of SFX-01 when treating common soft tissue sarcoma condition
MinervaX reveals completion of vaccine trial enrolment
The company is seeking to address the worldwide impact of group B streptococcus in older adults
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
Chronic kidney disease affects roughly 700 million patients worldwide
AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
The authorisation would include certain patients with refractory generalised myasthenia gravis
Blood Cancer UK extends collaboration with RareCan
The organisations will focus on the delivery of clinical trials which concentrate on rare cancers
